Oh, the days when it was socially acceptable to eat pure sugar in ice cold milk for breakfast. For those of us who grew up on breakfast cereal, the nostalgia runs deep for our old favorites,...
Food fads, like fashion fads, come and go throughout the decades. While there is plenty to gain by introducing a novel food item or concept, even those that succeed often don’t last long. A food...
Oh, the days when it was socially acceptable to eat pure sugar in ice cold milk for breakfast. For those of us who grew up on breakfast cereal, the nostalgia runs deep for our old favorites,...
Oh, the days when it was socially acceptable to eat pure sugar in ice cold milk for breakfast. For those of us who grew up on breakfast cereal, the nostalgia runs deep for our old favorites,...
The analysts at its underwriting firms are quite positive on Beam Therapeutics, now that its post-IPO quiet period has come to an end.
Veggie burgers, in the sense of patties made entirely out of such ingredients as legumes, mushrooms, grains, and nuts, have been around for thousands of years, especially in Asia and the Middle East....
Oh, the days when it was socially acceptable to eat pure sugar in ice cold milk for breakfast. For those of us who grew up on breakfast cereal, the nostalgia runs deep for our old favorites,...
A look at the areas most likely to be in the hurricane Dorian's path shows that about 668,0000 homes are at risk of damage. That could cost as much as $144 billion to repair.
Usually it’s a novel design or special features that are either unique to the car or are some sort of breakthrough at the time introduced some sort of breakthrough. But perhaps more than...
All four major U.S. mobile wireless carriers are posting speeds of more than 25 megabits per second, the lower limit to meet the definition of a broadband network.
Do you think Apple is embarrassed? With TS and her umbilicus, I gather, it's different. 
The top analyst upgrades, downgrades and initiations seen on Tuesday include Barrick Gold, Blackstone, Chesapeake Energy, Dollar Tree, Intel, Qualcomm, Sirius XM, Texas Instruments and Vale.
A series of new Stifel research reports focus on three biotech companies that have upcoming clinical data that could prove to be huge.
With 2018 coming to a close in just a few months, Merrill Lynch is taking a close look at the biotech industry and what key catalysts to expect before 2019.
The top analyst upgrades, downgrades and other research calls from Wednesday include Agilent, Alphabet, Amazon, Apple, Citigroup, Facebook, JPMorgan, Mattel and Netflix.